Protagenic Therapeutics (PTIX) announced the completion of enrollment and dosing in its Multiple Ascending Dose Phase 1 study evaluating its lead ...
Among people in prison, adding CXR or CRP to symptom screen was more effective than symptom screen alone. In addition to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback